NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

  News | News By Subject | News by Disease News By Date | Search News
   

Medrad, Inc. To Provide Direct Sales And Service In Belgium And Luxemburg
1/16/2006

INDIANOLA, Pa., Jan. 16 /PRNewswire/ -- MEDRAD Europe B.V., a subsidiary of the U.S.-based medical imaging device company MEDRAD, INC., has expanded its direct operation in Europe by establishing MEDRAD Belgium BVBA, which will provide direct sales, service and customer support in the Belgium and Luxemburg markets.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGO)

MEDRAD sales in Belgium and Luxemburg have grown steadily since it entered the market through a distributor in 1975. Customers will now have direct access to the product support and applications training that have earned MEDRAD its leading position in the worldwide market. "Taking customer satisfaction to the next level means providing our customers with expanded MEDRAD resources and expertise," says Peter Cleber, managing director of MEDRAD Europe B.V. "Our goal is to enable customers to maximize the effectiveness of MEDRAD products and services, and take full advantage of improvements in scanning technology."

MEDRAD Belgium BVBA sales efforts will be led by Paul-Henry Reard, who has over eight years of experience with MEDRAD products, and has also worked with monitoring, defibrillators, catheters and pharmaceutical products. Equipment service will be provided by MEDRAD's Service team, led by Hans van Winkel, and Customer Support will be led by Mady Hensen. The MEDRAD Belgium BVBA staff can be contacted at 0800-72035.

MEDRAD has direct sales and service in 10 European countries and is represented by distributor operations in 35 European countries, with European headquarters in Maastricht, The Netherlands.

MEDRAD, INC. is a worldwide leading provider of medical devices and services that enable and enhance imaging procedures of the human body. Used in diagnostic imaging, MEDRAD's product offerings include a comprehensive line of vascular injection systems, magnetic resonance (MR) surface coils and patient care products, and equipment services. Total 2004 revenues were $343 million. MEDRAD, INC. is a 2003 recipient of the Malcolm Baldrige National Quality Award, the top honor a U.S. company can receive for quality and business excellence. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD, INC. is a U.S. affiliate of Schering AG, Germany . For more information, visit MEDRAD's website at www.medrad.com.

Cautionary statement regarding forward-looking statements.

Certain statements in this press release that are neither reported financial results nor other historical information are forward-looking statements, including but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results and MEDRAD's plans and objectives to differ materially from those expressed or implied in the forward-looking statements. MEDRAD undertakes no obligation to update publicly or revise any of these forward-looking statements, whether to reflect new information or future events, circumstances or otherwise.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comMEDRAD, INC.

CONTACT: Luanne S. Radermacher, Corporate Affairs of MEDRAD, INC.,+1-412-767-2400 ext. 3184, or lradermacher@medrad.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES